Related Experiment Video
Updated: Feb 1, 2026

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model
Published on: March 20, 2020
Ursolic Acid Promotes the Sensitization of rhTRAIL-resistant Triple-negative Breast Cancer
Jasmine M Manouchehri1,2, Michael Kalafatis3,2,4
1Department of Chemistry, Science and Research Center, Cleveland State University, Cleveland, OH, U.S.A.
Background/Aim:
Triple-negative breast cancer (TNBC) can be characterized as the deadliest breast cancer type considering the lack of efficacious therapeutics. Recombinant human tumor necrosis factor-related apoptosis-inducing ligand (rhTRAIL) is an encouraging anti-cancer therapeutic with the capacity to induce apoptosis in cancer cells but there are TNBCs less susceptible to rhTRAIL. The aim of this study was to assess the potential of the natural product ursolic acid (UA) to sensitize of rhTRAIL-resistant TNBCs.
Materials And Methods:
In order to evaluate apoptosis induction in rhTRAIL and UA-treated TNBC BT-20 and HCC1937 cells that are resistant to rhTRAIL, western blot analysis and Annexin V/PI assays were executed.
Results:
UA increased the expression of death receptors 4 and 5 and decreased the expression of c-FLIPL transcriptionally sensitizing rhTRAIL-resistant TNBC cells to apoptosis induced by rhTRAIL.
Conclusion:
UA is a possible potent sensitizer of rhTRAIL-resistant TNBCs to rhTRAIL-induced apoptosis.
Related Concept Videos
Treatment Resistant Cancers
The Eukaryotic Promoter Region
Scalar and Vector Triple Products
The scalar triple product is the dot product of a vector with the cross product of two vectors....
Negative Regulator Molecules
Positive, Negative, and Zero Work
Amino acids

